Wild-type p53 and TGF-β are key tumour suppressors which regulate an array of cellular responses. TGF-β signals in part via the Smad signal transduction pathway. Wild-type p53 and Smads physically interact and coordinately induce transcription of a number of key tumour suppressive genes. Conversely mutant p53 generally subverts tumour suppressive TGF-β responses, diminishing transcriptional activation of key TGF-β target genes. Mutant p53 can also interact with Smads and this enables complex formation with the p53 family member p63 and blocks p63-mediated activation of metastasis suppressing genes to promote tumour progression. p53 and Smad function may also overlap during miRNA biogenesis as they can interact with the same components of th...
peer reviewedProteasome activity is frequently enhanced in cancer to accelerate metastasis and tumor...
<div><p>The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation d...
The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation domain tr...
Wild-type p53 and TGF-ß are key tumour suppressors which regulate an array of cellular responses. TG...
AbstractThe p53 tumor suppressor belongs to a family of proteins that sense multiple cellular inputs...
The p53 tumor suppressor is the focus of intense investigation. It is considered a latent transcript...
The p53 tumor suppressor belongs to a family of proteins that sense multiple cellular inputs to regu...
A fundamental function of the tumor suppressors p53 and TGFβ is protection of cells against cellular...
Transforming growth factor β (TGF β) is one of the crucial cytokine playing an important role in dev...
The product of the TP53 gene, p53, is one of the most recognised and extensively studied molecules t...
Specific p53 mutations abrogate the tumor suppressive functions by gaining new abilities to promote ...
We present an integromic analysis of gene alterations that modulate transforming growth factor β (TG...
SummaryTGFβ ligands act as tumor suppressors in early stage tumors but are paradoxically diverted in...
The TP53 tumour suppressor gene is mutated in approximately 50% of all human cancers. The majority o...
We present an integromic analysis of gene alterations that modulate transforming growth factor β (TG...
peer reviewedProteasome activity is frequently enhanced in cancer to accelerate metastasis and tumor...
<div><p>The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation d...
The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation domain tr...
Wild-type p53 and TGF-ß are key tumour suppressors which regulate an array of cellular responses. TG...
AbstractThe p53 tumor suppressor belongs to a family of proteins that sense multiple cellular inputs...
The p53 tumor suppressor is the focus of intense investigation. It is considered a latent transcript...
The p53 tumor suppressor belongs to a family of proteins that sense multiple cellular inputs to regu...
A fundamental function of the tumor suppressors p53 and TGFβ is protection of cells against cellular...
Transforming growth factor β (TGF β) is one of the crucial cytokine playing an important role in dev...
The product of the TP53 gene, p53, is one of the most recognised and extensively studied molecules t...
Specific p53 mutations abrogate the tumor suppressive functions by gaining new abilities to promote ...
We present an integromic analysis of gene alterations that modulate transforming growth factor β (TG...
SummaryTGFβ ligands act as tumor suppressors in early stage tumors but are paradoxically diverted in...
The TP53 tumour suppressor gene is mutated in approximately 50% of all human cancers. The majority o...
We present an integromic analysis of gene alterations that modulate transforming growth factor β (TG...
peer reviewedProteasome activity is frequently enhanced in cancer to accelerate metastasis and tumor...
<div><p>The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation d...
The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation domain tr...